GGrantIndex
← Leaderboards

Anna Tate Riegel

Georgetown University

$14,353,372
Attributed
$14,649,945
Total exposure
6
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,649,945 · 6

By mechanism

T32$8,398,023 · 1
R01$5,176,787 · 2
R21$1,075,135 · 3

Top collaborators

Most similar at Georgetown University

Same institution · by research overlap

Others in their field

Top investigators on “Grant

Research focus

GrantTrainingTumor BiologyCellsIn VivoIn VitroMammary GlandSignal TransductionMalignant Breast NeoplasmProtein IsoformsTumor ProgressionOverexpressionNcoa3 GenePathway InteractionsPreventMatrigelGene ExpressionReportingSignal PathwayTumorOncogenesBreastEpithelialLength

Grant awards (41)

Mechanism and pathways of Glucocorticoid Receptor (GR) signaling in TNBC progression$395,356
R21 · FY2025 · CA · contact PI
Training Grant In Tumor Biology$112,003
T32 · FY2025 · CA
Training Grant In Tumor Biology$332,856
T32 · FY2024 · CA
Training Grant In Tumor Biology$304,503
T32 · FY2023 · CA · contact PI
Training Grant In Tumor Biology$388,054
T32 · FY2022 · CA · contact PI
Training Grant In Tumor Biology$486,639
T32 · FY2021 · CA · contact PI
(PQ6) Molecular Mechanisms Driving Benign to Malignant Transitions in Breast Cancer$457,974
R01 · FY2020 · CA · contact PI
Training Grant In Tumor Biology$202,175
T32 · FY2020 · CA · contact PI
Development of clinically relevant models of DCIS$167,779
R21 · FY2020 · CA · contact PI
(PQ6) Molecular Mechanisms Driving Benign to Malignant Transitions in Breast Cancer$444,234
R01 · FY2019 · CA · contact PI
Training Grant In Tumor Biology$390,949
T32 · FY2019 · CA · contact PI
Development of clinically relevant models of DCIS$201,600
R21 · FY2019 · CA · contact PI
Training Grant in Tumor Biology$598,069
T32 · FY2018 · CA · contact PI
(PQ6) Molecular Mechanisms Driving Benign to Malignant Transitions in Breast Cancer$457,974
R01 · FY2018 · CA · contact PI
Training Grant in Tumor Biology$588,699
T32 · FY2017 · CA · contact PI
(PQ6) Molecular Mechanisms Driving Benign to Malignant Transitions in Breast Cancer$457,974
R01 · FY2017 · CA · contact PI
Training Grant in Tumor Biology$4,864
T32 · FY2017 · CA · contact PI
Training Grant in Tumor Biology$482,229
T32 · FY2016 · CA · contact PI
(PQ6) Molecular Mechanisms Driving Benign to Malignant Transitions in Breast Cancer$469,489
R01 · FY2016 · CA · contact PI
Training Grant in Tumor Biology$520,974
T32 · FY2015 · CA · contact PI
Role of AIB1 in malignant progression$287,453
R01 · FY2015 · CA · contact PI
Training Grant in Tumor Biology$471,850
T32 · FY2014 · CA · contact PI
Role of AIB1 in malignant progression$278,829
R01 · FY2014 · CA · contact PI
Training Grant in Tumor Biology$502,575
T32 · FY2013 · CA · contact PI
Role of AIB1 in malignant progression$270,206
R01 · FY2013 · CA · contact PI
Training Grant in Tumor Biology$466,626
T32 · FY2012 · CA · contact PI
Role of AIB1 in malignant progression$287,453
R01 · FY2012 · CA · contact PI
Training Grant in Tumor Biology$456,298
T32 · FY2011 · CA · contact PI
Role of AIB1 in malignant progression$287,453
R01 · FY2011 · CA · contact PI
Training Grant in Tumor Biology$324,882
T32 · FY2010 · CA · contact PI
Training Grant in Tumor Biology$485,705
T32 · FY2009 · CA · contact PI
Role of AIB1 in Growth Factor Signaling$290,637
R01 · FY2009 · CA · contact PI
Training Grant in Tumor Biology$477,034
T32 · FY2008 · CA · contact PI
Role of AIB1 in Growth Factor Signaling$290,637
R01 · FY2008 · CA · contact PI
Training Grant in Tumor Biology$473,577
T32 · FY2007 · CA · contact PI
Role of AIB1 in Growth Factor Signaling$290,637
R01 · FY2007 · CA · contact PI
Training Grant in Tumor Biology$327,462
T32 · FY2006 · CA · contact PI
Role of AIB1 in Growth Factor Signaling$299,317
R01 · FY2006 · CA · contact PI
Role of AIB1 in Growth Factor Signaling$306,520
R01 · FY2005 · CA
Pancreas Cancer Specialized Program of Research Excelle*$155,200
R21 · FY2004 · CA
Pancreas Cancer Specialized Program of Research Excelle*$155,200
R21 · FY2003 · CA